These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27659882)

  • 1. Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study.
    Suzuki T; Agarwal SK; Deo R; Sotoodehnia N; Grams ME; Selvin E; Calkins H; Rosamond W; Tomaselli G; Coresh J; Matsushita K
    Am Heart J; 2016 Oct; 180():46-53. PubMed ID: 27659882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in novel filtration markers and risk of ESRD.
    Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
    Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CKD Prevalence and Incidence in Older Adults Using Estimated GFR With Different Filtration Markers: The Atherosclerosis Risk in Communities Study.
    Flaherty CM; Surapaneni A; Seegmiller JC; Coresh J; Grams ME; Ballew SH
    Kidney Med; 2024 Oct; 6(10):100893. PubMed ID: 39319210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study.
    Scheppach JB; Coresh J; Wu A; Gottesman RF; Mosley TH; Knopman DS; Grams ME; Sharrett AR; Koton S
    Am J Kidney Dis; 2020 Dec; 76(6):775-783. PubMed ID: 32428540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
    Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
    JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.
    Foster MC; Levey AS; Inker LA; Shafi T; Fan L; Gudnason V; Katz R; Mitchell GF; Okparavero A; Palsson R; Post WS; Shlipak MG
    Am J Kidney Dis; 2017 Sep; 70(3):406-414. PubMed ID: 28549536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
    Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ballew SH; Chen Y; Daya NR; Godino JG; Windham BG; McAdams-DeMarco M; Coresh J; Selvin E; Grams ME
    Am J Kidney Dis; 2017 Feb; 69(2):228-236. PubMed ID: 27884475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
    Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
    BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease.
    Yang C; Kwak L; Ballew SH; Garimella PS; Jaar BG; Folsom AR; Heiss G; Selvin E; Lutsey PL; Coresh J; Matsushita K
    Atherosclerosis; 2017 Dec; 267():167-174. PubMed ID: 28992939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
    Chen DC; Scherzer R; Ix JH; Kramer HJ; Crews DC; Nadkarni G; Gutierrez O; Bullen AL; Ilori T; Garimella PS; Shlipak MG; Estrella MM
    Am J Kidney Dis; 2024 Apr; 83(4):489-496.e1. PubMed ID: 37866793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome.
    Wang J; Liu Y; Jin R; Zhao X; Wu Z; Han Z; Xu Z; Guo X; Tao L
    Nephrol Dial Transplant; 2024 Apr; 39(5):860-872. PubMed ID: 37930847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.
    Kim H; Wang D; Chalmers J; Jun M; Zoungas S; Marre M; Hamet P; Harrap S; Mancia G; Poulter NR; Cooper ME; Woodward M; Selvin E; Rebholz CM
    J Diabetes; 2020 Dec; 12(12):929-941. PubMed ID: 32609422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of estimated glomerular filtration rate from serum creatinine and cystatin C with new-onset diabetes: a nationwide cohort study in China.
    Zhang Z; He P; Zhou C; Liu M; Liu C; Li H; Zhang Y; Li Q; Zhang Y; Wang G; Liang M; Qin X
    Acta Diabetol; 2021 Sep; 58(9):1269-1276. PubMed ID: 33909121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
    Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between estimated glomerular filtration rate by creatinine versus cystatin C in different patient care settings.
    Liu L; Chang DY; Lewandrowski KB; Dighe AS
    Clin Biochem; 2024 Oct; 131-132():110801. PubMed ID: 39029611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular filtration rate estimated by differing measures and risk of all-cause mortality among Chinese individuals without or with diabetes: A nationwide prospective study.
    Liu YJ; Li FR; Chen CL; Wan ZX; Chen JS; Yang J; Liu R; Xu JY; Zheng Y; Qin LQ; Chen GC
    J Diabetes; 2023 Jun; 15(6):508-518. PubMed ID: 37128173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
    Ide H; Iwase M; Fujii H; Ohkuma T; Kaizu S; Jodai T; Kikuchi Y; Idewaki Y; Sumi A; Nakamura U; Kitazono T
    Clin Exp Nephrol; 2017 Jun; 21(3):383-390. PubMed ID: 27339449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.